Recruiting studies: Fetal Hemoglobin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome
NA · 1 location(s) · Chinese University of Hong Kong · NCT05797272 Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates
Phase N/A · 1 location(s) · Medical University of Graz · NCT07672275 Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05213572 Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia
Phase 2 · 1 location(s) · National Institute of Blood and Marrow Transplant (NIBMT), P · NCT06490627 MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05735717 Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · Abdullah Kutlar · NCT01245179

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.